borax boiron 30ch pilules
boiron - borax 30ch 1 % - pillules - 30ch - borax 30ch 1 %
borax boiron 6k pilules
boiron - borax 6k 1 % - pillules - 6k - borax 6k 1 %
borax boiron 30k pilules
boiron - borax 30k 1 % - pillules - 30k - borax 30k 1 %
borax boiron 200k pilules
boiron - borax 200k 1 % - pillules - 200k - borax 200k 1 %
borax boiron 200k pilules single-dose cont.
boiron - borax 200k 1 % - pillules in single-dose container - 200k - borax 200k 1 %
borax boiron mk pilules single-dose cont.
boiron - borax mk 1 % - pillules in single-dose container - mk - borax mk 1 %
borax boiron xmk pilules single-dose cont.
boiron - borax xmk 1 % - pillules in single-dose container - xmk - borax xmk 1 %
vpriv 400
takeda israel ltd - velaglucerase alfa - lyophilized powder for solution for infusion - velaglucerase alfa 400 u/vial - velaglucerase alfa - velaglucerase alfa - vpriv is a hydrolytic glucocerebroside – specific enzyme indicated for the long term replacement therapy (ert) for pediatric and adult patients with type 1 gaucher disease.
elelyso taliglucerase alfa rpc 200 units powder for injection
pfizer australia pty ltd - taliglucerase alfa, quantity: 212 u - injection, powder for - excipient ingredients: mannitol; citric acid; sodium citrate dihydrate; polysorbate 80 - elelyso is indicated for long-term enzyme replacement therapy for adult and paediatric patients with a confirmed diagnosis of type 1 gaucher disease associated with at least one of the following: splenomegaly, hepatomegaly, anaemia, thrombocytopenia.
vpriv velaglucerase alfa (ghu) 400 units powder for solution for infusion, glass vial
takeda pharmaceuticals australia pty ltd - velaglucerase alfa, quantity: 400 u - injection, powder for - excipient ingredients: citric acid monohydrate; sucrose; polysorbate 20; sodium citrate dihydrate - vpriv is indicated for long-term enzyme replacement therapy (ert) for paediatric and adult patients with type 1 gaucher disease.